News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
MarketBeat Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
This article provides an AI-driven analysis of Catalyst Bancorp Inc. (NASDAQ: CLST), highlighting strong near-term sentiment with a potential shift to neutrality mid-term and a positive long-term bias. It details exceptional risk-reward short setup, current price signals, and three distinct trading strategies (Position, Momentum …
Verisk Analytics is gaining attention due to the increased adoption of its AI-enhanced platforms, XactAI and Core Lines Reimagine, which are driving subscription-based revenue. This growth highlights a tension between investor enthusiasm for AI-driven recurring revenue and concerns about the company's valuation and potential …
Principal Financial Group Inc. increased its holdings in Annaly Capital Management Inc. by 3.7% in Q2 2026, purchasing an additional 60,537 shares, bringing its total to 1.68 million shares valued at $37.6 million. Annaly Capital Management (NLY) has received a "Moderate Buy" consensus rating …
TD Asset Management Inc. increased its stake in Annaly Capital Management Inc. by 25.1%, bringing its total holdings to 519,768 shares valued at $11.6 million. Annaly Capital Management exceeded analyst expectations with quarterly earnings of $0.79 per share and revenue of $1.82 billion, and …
Zacks Research downgraded Mineralys Therapeutics (NASDAQ:MLYS) to a "Strong Sell" rating, despite a mixed analyst sentiment with an average "Hold" rating and a $49.33 price target. The downgrade follows a significant earnings miss, with the company reporting a quarterly loss of $2.85 per share …
Oppenheimer Asset Management Inc. has acquired a new position in Verisk Analytics, Inc. (NASDAQ:VRSK), purchasing 111,878 shares valued at approximately $20.085 million during the second quarter. The article also details other institutional investor activities, Verisk Analytics' recent financial performance, dividend announcement, and analyst ratings. …
Pictet Asset Management Holding SA increased its stake in Annaly Capital Management Inc. by 12.1% during the second quarter, purchasing an additional 45,402 shares and bringing its total holdings to 419,836 shares valued at $9.39 million. Other institutional investors like Vanguard Group Inc., State …
Wall Street Zen downgraded Mineralys Therapeutics (NASDAQ:MLYS) to "Strong Sell" following a significant second-quarter earnings miss, where the company lost $2.85 per share against an expected $0.55 loss. Despite this, the broader analyst consensus remains a "Moderate Buy" with a $49.33 price target. Insider …
Wall Street Zen has downgraded Avalyn Pharma (NASDAQ:AVLN) from a "hold" to a "sell" rating, despite the overall analyst sentiment being a "Moderate Buy" with a $60 average price target. Other firms like Jefferies, Guggenheim, and Evercore have issued "buy" or "outperform" ratings, while …
Novo Holdings A/S, an investment firm owned by the Novo Nordisk Foundation, has reported an 8.8% beneficial stake in Avalyn Pharma Inc. The firm holds 3,883,289 shares of Avalyn Pharma's voting common stock, with sole voting and dispositive power over these shares. The Novo …
A group of investment entities associated with Clint D. Coghill has reported a 9.6% ownership stake in Health Catalyst (HCAT) as of June 30, 2026. This includes direct holdings by Stoney Lonesome HF LP and Drake Helix Holdings, LLC. Clint D. Coghill and CDC …
Catalyst Bancorp, Inc. reported its Q2 2026 results, showing modest revenue growth of 3.6% year-over-year to $3.584 million and essentially flat net income and diluted EPS at $524K and $0.14, respectively. The company highlighted strategic shifts, including the completion of a merger with Lakeside …
AllianceBernstein L.P. has filed an amended Schedule 13G/A, disclosing a 4.6% beneficial ownership stake in Verisk Analytics Inc., totaling 6,008,136 shares. These shares are held for investment purposes in client discretionary investment advisory accounts. The filing details AllianceBernstein's sole voting power over 5,773,111 shares …
This article provides a compilation of recent news and updates regarding Qualys Inc. (QLYS), highlighting its strong Q2 2026 earnings, increased guidance, and an upgrade to a Strong Buy rating by Zacks. It also mentions Qualys' participation in investor conferences and its role as …
Parnassus Investments, an investment management company, released the "Parnassus Core Equity Fund" second quarter of 2026 investor letter. A copy of the letter can be downloaded here. The fund returned 16.83% in the second quarter of 2026, outperforming the S&P 500's 15.20% gain. Performance …
Sharemaestro market context Price below Trend Line 52 weeks -43.9% · Next-week setup negative 37.6%Verisk Analytics (VRSK) is gaining attention due to its recent stock performance, driven by subscription growth and advancements in insurance software and AI tools. While a popular narrative suggests the stock is 142% overvalued at $185.94 compared to a fair value of $76.85, Simply …
Sharemaestro market context Price below Trend Line 52 weeks -43.9% · Next-week setup negative 37.6%The 12-month average price target for Qualys, Inc. (QLYS) stock has been raised by analysts from $176.62 to $180.07, with individual forecasts ranging from $130 to $220. Despite the increase, this new target implies an approximate 8% potential downside based on the August 13 …
Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Senior Vice President of Finance and Investor Relations - Stephanie St. ClairChief Executive Officer - Benjamin AlbertChief Financial Officer - Jason Alger TAKEAWAYS Total Revenue -- $70.5 million, …
Mineralys Therapeutics insider David Rodman has filed a Form 144, indicating his intention to sell up to 14,056 shares of common stock through Merrill Lynch on or after August 13, 2026. The aggregate market value of the planned sale is $372,187.00. These shares originate …
Verisk Analytics Inc. (NASDAQ: VRSK) is showing weak sentiment across all time horizons, supporting a short bias. The article details an exceptional 41.2:1 risk-reward short setup targeting an 11.9% downside. It also provides institutional trading strategies including long, breakout, and short positions with specific …
Mineralys Therapeutics, Inc. announced an inducement stock option award of 135,000 shares and a restricted stock unit award of 102,400 shares to Dr. Terry Ferguson, their new Chief Medical Officer. These awards, granted on August 10, 2026, are part of the company's 2025 Employment …
Search by ticker symbol or company name and select a result to open its chart.